Literature DB >> 7506453

Frozen section evaluation of donor livers before transplantation.

R S Markin1, J L Wisecarver, S J Radio, R J Stratta, A N Langnas, K Hirst, B W Shaw.   

Abstract

Frozen section examination was performed on 385 donor livers before transplantation. Exclusion criteria were applied to the donor livers examined to exclude potentially dysfunctional livers. The exclusion criteria included the following: severe macrovesicular steatosis, ischemic necrosis, prominent chronic portal inflammation, prominent periductular fibrosis, granulomatous inflammation, bridging fibrosis, and malignancy. Twenty-seven of the 385 donor livers examined were excluded before transplantation. The following histologic features were present in the excluded livers: severe steatosis (22), ischemic necrosis (2), portal inflammation (1), and periductular fibrosis (2). Steatosis was present in 51 of the 385 (13.25%) organs examined, including 22 of the donor organs excluded before transplantation. Twenty-nine livers with mild to moderate steatosis were implanted into size and blood type-matched recipients. Indicators of allograft function (prothrombin time and bilirubin) and damage (aspartate aminotransferase and alanine aminotransferase) were measured daily for the first 10 days after transplant. There was no statistically significant difference between the group of nonfat livers and donor livers containing mild steatosis. Statistically significant higher posttransplant serum alanine aminotransferase and prothrombin time levels were present in the patients with livers implanted with mild versus moderate steatosis. The 1-year survival rate for patients receiving fatty versus nonfatty donor livers was not statistically different (Kaplan-Meier, P = 0.592). No significant differences were found in the clinical and laboratory characteristics of donors whose organs were implanted compared with the clinical and laboratory characteristics of donors whose organs were excluded. The primary nonfunction rate after applying the exclusion criteria was 1.4%, which is a significant decrease compared with our primary nonfunction rate of 8.5% before using frozen section examination. Frozen section examination is useful in excluding donor organs which may become dysfunctional after transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506453     DOI: 10.1097/00007890-199312000-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  Effects of ischemia-reperfusion on hepatic glutathione and plasmatic markers of graft function during in situ split-liver transplantation in adult recipients.

Authors:  G Santori; E Andorno; I Fontana; D Cottalasso; U Valente
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment.

Authors:  Stefan Biesterfeld; Jasmin Knapp; Fernando Bittinger; Heiko Götte; Martin Schramm; Gerd Otto
Journal:  Virchows Arch       Date:  2012-07-08       Impact factor: 4.064

3.  Use of marginal grafts in deceased donor liver transplant: assessment of early outcomes.

Authors:  Rajesh Godara; C Sudeep Naidu; Pankaj P Rao; Sanjay Sharma; Jayant K Banerjee; Anupam Saha; Kapileshwer Vijay
Journal:  Indian J Gastroenterol       Date:  2013-09-03

Review 4.  [Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas].

Authors:  C Mogler; C Flechtenmacher; P Schirmacher; F Bergmann
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

5.  Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

Authors:  Joseph Benton Oliver; Andrea Fleisch Marcus; Mark Paster; Joseph Nespral; Advaith Bongu; George Dikdan; Lloyd Brown; Nikole Neidlinger; Baburao Koneru
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Microanatomical Location of Hyaluronic Acid Gel Following Injection of the Upper Lip Vermillion Border: Comparison of Needle and Microcannula Injection Technique.

Authors:  Alexander D Blandford; Catherine J Hwang; Jason Young; Alexander C Barnes; Thomas P Plesec; Julian D Perry
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 May/Jun       Impact factor: 1.746

Review 7.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

Review 8.  Current concept of small-for-size grafts in living donor liver transplantation.

Authors:  Toru Ikegami; Mitsuo Shimada; Satoru Imura; Yusuke Arakawa; Akira Nii; Yuji Morine; Hirofumi Kanemura
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.

Authors:  Chi-Dan Wan; Chun-You Wang; Tao Liu; Rui Cheng; Hong-Bo Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

10.  Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome.

Authors:  Henning Reis; Patricia T Peterek; Jeremias Wohlschlaeger; Gernot M Kaiser; Zoltan Mathe; Benjamin Juntermanns; Georgios C Sotiropoulos; Ulrich Beckhove; Ali Canbay; Ulrike Wirges; Andre Scherag; Juergen-Walter Treckmann; Andreas Paul; Hideo Andreas Baba
Journal:  Virchows Arch       Date:  2013-12-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.